Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Edwards Lifesciences
EW
$51.7B
| $97.9M | 0.05% |
945,033
+216,339
| +30% | +$20.4M |
|
302
CALL
iShares MSCI Brazil ETF
EWZ
$8.95B
| $97.3M | 0.05% |
2,400,000
+1,026,800
| +75% | +$38.8M |
|
303
ARK Innovation ETF
ARKK
$6.31B
| $97.2M | 0.05% |
743,112
+618,095
| +494% | +$72M |
|
304
Allstate
ALL
$67.5B
| $96.9M | 0.05% |
742,887
+102,411
| +16% | +$13.2M |
|
305
Dow Inc
DOW
$21.2B
| $96.8M | 0.05% |
1,529,448
+226,484
| +17% | +$15M |
|
306
iShares Russell 1000 Growth ETF
IWF
$128B
| $96.8M | 0.05% |
1,425,836
+1,387,752
| +3,644% | +$89.5M |
|
|
CERN
307
DELISTED
Cerner Corp
CERN
| $96.6M | 0.05% |
1,236,411
+317,592
| +35% | +$24.4M |
|
|
PXD
308
PUT
DELISTED
Pioneer Natural Resource Co.
PXD
| $95.9M | 0.05% |
590,100
+206,200
| +54% | +$32.4M |
|
309
Vanguard Total International Bond ETF
BNDX
$82.2B
| $95.8M | 0.05% |
1,678,411
+1,411,005
| +528% | +$80.4M |
|
310
Wayfair
W
$14.6B
| $95.4M | 0.05% |
302,168
+36,762
| +14% | +$11.5M |
|
311
Lennar Class A
LEN
$21.2B
| $95.2M | 0.05% |
990,274
-24,652
| -2% | -$2.38M |
|
312
Emerson Electric
EMR
$88.3B
| $95.2M | 0.05% |
988,729
+89,303
| +10% | +$8.4M |
|
313
Public Storage
PSA
$61.3B
| $94.6M | 0.04% |
314,457
-13,686
| -4% | -$3.84M |
|
|
MXIM
314
DELISTED
Maxim Integrated Products
MXIM
| $94.5M | 0.04% |
897,113
+154,795
| +21% | +$15.2M |
|
315
Mercado Libre
MELI
$92.3B
| $93.7M | 0.04% |
60,118
+4,299
| +8% | +$6.31M |
|
316
Zimmer Biomet
ZBH
$18.4B
| $93M | 0.04% |
595,880
+11,224
| +2% | +$1.82M |
|
|
BNY
317
Bank of New York Mellon
BNY
$107B
| $92.9M | 0.04% |
1,813,246
+202,454
| +13% | +$10.1M |
|
318
Becton Dickinson
BDX
$48.2B
| $92.5M | 0.04% |
389,742
-34,022
| -8% | -$8.16M |
|
319
Zscaler
ZS
$27.3B
| $92.1M | 0.04% |
426,280
-46,820
| -10% | -$8.9M |
|
|
ZEN
320
DELISTED
ZENDESK INC
ZEN
| $91.3M | 0.04% |
632,701
+64,027
| +11% | +$9.04M |
|
321
Boston Scientific
BSX
$71.5B
| $90.5M | 0.04% |
2,117,551
+523,967
| +33% | +$22M |
|
322
EOG Resources
EOG
$70.7B
| $89.6M | 0.04% |
1,073,669
+274,838
| +34% | +$21.7M |
|
323
PUT
Amdocs
DOX
$6.22B
| $89.4M | 0.04% |
1,156,200
+528,800
| +84% | +$40.8M |
|
324
PUT
Sea Limited
SE
$69.5B
| $89.4M | 0.04% |
325,600
+187,900
| +136% | +$47.7M |
|
325
PUT
Beyond Meat
BYND
$277M
| $89.3M | 0.04% |
567,300
+164,100
| +41% | +$21.8M |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.